Associated Papers
Elacestrant plus alpelisib in an ESR1 and PIK3CA co-mutated and heavily pretreated metastatic breast cancer: the first case report for combination efficacy and safety.
Tokat ÜM et al.
Therapeutic Advances in Medical Oncology, 2024
Select a paper to view details